Sidny
Senior Member
- Messages
- 176
-
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
New Alzheimer’s Study - Guess What Was Hanging Out In Brain Tissues - HHV-6A & HHV-7
- Thread starter Wally
- Start date
- Messages
- 97
- Location
- Vancouver, WA
This hit the headlines in 2015.
http://www.einstein.yu.edu/news/rel...pends-traditional-approach-and-shows-promise/
It looks like one of the strategies that herpes viruses use to defeat immune response is to provide a 'decoy' target for antigens. Attached to the surface of the viral capsid is a glycoprotein, called glycoprotein D, that allows the virus to enter a cell. It seems to have a secondary purpose of prompting an immune response that is only partially effective in fighting infection, thereby allowing the virus to survive the immune response long enough to cause the host to become contagious.
Hosts who have not been infected with either HSV1 or HSV2 are able to acquire immunity with the Einstein vaccine. But if a host has been infected with either HSV1 or HSV2, the vaccine is much less effective. I wonder if lowering the white blood cell count of a host will improve the immune response of the host to the vaccine and allow immunity.
- Paul